Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.33 BRL | +3.18% | +3.96% | -10.20% |
Mar. 04 | Barclays Downgrades Ambev to Equalweight From Overweight, Adjusts Price Target to $3 From $3.50 | MT |
Feb. 29 | Transcript : Ambev S.A., Q4 2023 Earnings Call, Feb 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.20% | 36.95B | |
-4.18% | 119B | |
-1.48% | 55.14B | |
+5.10% | 46.46B | |
-2.35% | 22.83B | |
+9.23% | 18.96B | |
+3.25% | 17.45B | |
+5.41% | 14.93B | |
+9.73% | 12.78B | |
-5.57% | 12.11B |
- Stock Market
- Equities
- ABEV3 Stock
- News Ambev S.A.
- UBS Adjusts Ambev Price Target to $3.20 From $3.50, Maintains Buy Rating